Biktarvy, formally known as bictegravir, represents a potent single-tablet regimen for controlling HIV infection. This drug combines three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the virus's ability to replicate within the body, considerably decreasing the viral burden. For many indivi